IL6 and rheumatoid arthritis: Additionally, current RA drugs such as TNF-α inhibitors and IL-6 inhibitors primarily function by blocking specific inflammatory pathways.44,45 In contrast, itaconate can regulate multiple immune and inflammatory responses, potentially benefiting patients who do not respond well to traditional therapies.